ArticleBMJ open2026
Hospital services utilisation of patients with vestibular disease in France: a retrospective nationwide study using electronic hospital health records.
Article in BMJ open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Prevalence and direct costs of vestibular disease in France - matched case-control study results from the 2022 and 2023 french health data system.Cost effectiveness and resource allocation : C/E · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesWhile most acute vestibular disorders do not require a hospital stay, admission to inpatient care because of acute vertigo, dizziness and balance problems (VDB) seems to be more frequent than necessary. The aim of this study was to analyse the frequency and regional distribution of hospital admissions for acute VDB and to estimate the associated healthcare costs.
settingWe used the complete database of inpatient stays from the French healthcare system between January 2014 and December 2022.
participantsPatients were included if they had a typical diagnosis code and at least one of the diagnostic or therapeutic procedures for vestibular diseases. Information on regional deprivation and physician density at a regional level is included in our analyses. PRIMARY AND SECONDARY OUTCOME MEASURES: Inpatient stay for acute VDB.
resultsOut of 277 409 765 hospitalisations, a total of 482 578 inpatient stays could be directly attributed to VDB as a primary diagnosis. Patients were predominantly female (range 63.0%-64.3%) and older (from 2014 to 2022, mean age 52.8 to 56.0 years). Total costs per year ranged from 61.3 million euros in 2020 to 72.8 million in 2021 with an average cost per case ranging between 1237 and 1394 euros. There was a positive association between age, general practitioner density, neurologist density and a high hospitalisation rate of the respective area with β=0.01 (95% CI 0.003 to 0.02; p=0.0005), β=0.13 (95% CI 0.12 to 0.14; p<0.0001) and β=1.49 (95% CI 1.28 to 1.70; p<0.0001), respectively. A negative association between otorhinolaryngologist density β=-2.41 (95% CI-2.49 to -2.33 p<0.0001) and rate was found.
conclusionsHigh social deprivation was independently associated with higher hospitalisation rates. We show considerable regional variations of hospital admissions for VDB in France. Awareness and training efforts for VDB must be increased.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.